Core Viewpoint - The announcement of a new childcare subsidy policy in China is expected to significantly benefit the infant and child-related stocks, leading to notable increases in their market performance [1]. Group 1: Stock Performance - H&H International Holdings (01112) rose by 4.28%, trading at 11.7 HKD [1] - Jinxin Fertility (01951) increased by 3.73%, trading at 3.34 HKD [1] - Beikang Medical-B (02170) saw a rise of 2.41%, trading at 2.98 HKD [1] - China Feihe (06186) grew by 1.7%, trading at 4.79 HKD [1] Group 2: Policy Announcement - The State Council Information Office will hold a press conference on July 30, 2023, to discuss the childcare subsidy system and related measures [1]. - Starting from January 1, 2025, families will receive an annual subsidy of 3600 CNY for each child until they reach three years old, regardless of whether they have one, two, or three children [1]. - For children born before January 1, 2025, and under three years old, the subsidy will be calculated based on the number of months eligible [1]. Group 3: Market Analysis - According to CITIC Securities, four sectors are expected to benefit the most: dairy products, maternal and infant retail, infant products, and postpartum care services [1]. - The market size for infant formula is projected to grow from 200 billion CNY to 300 billion CNY by 2025 [1]. - Maternal and infant retail is expected to maintain a growth rate of over 20% [1]. - The infant products market will continue to expand due to consumption upgrades [1]. - Postpartum care services are anticipated to be the fastest-growing segment, with an annual growth rate exceeding 30% [1].
港股异动 婴童概念股表现活跃 H&H国际控股(01112)涨超4% 锦欣生殖(01951)涨超3%